Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH -16.56%15 EBITDA Margin % is 31.98% as of Mar. 2025, which is 87% above its 10-year median of 17.14. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 672 Healthcare Providers & Services companies, ABH Healthcare ranks better than 89.73% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. ABH Healthcare's EBITDA for the
three
months ended in Mar. 2025 was ₹41.2 Mil. ABH Healthcare's Revenue for the
three
months ended in Mar. 2025 was ₹128.8 Mil. Therefore, ABH Healthcare's EBITDA margin for the quarter that ended in Mar. 2025 was 31.98%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
ABH Healthcare EBITDA Margin % Related Terms
ABH Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for ABH Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare EBITDA Margin % Chart
ABH Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
EBITDA Margin %
6.81
14.38
18.93
26.33
ABH Healthcare Quarterly Data
Mar25
EBITDA Margin %
31.98
NSE:ABH vs : EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare (NSE:ABH) has a EBITDA Margin % of 31.98% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ABH Healthcare and its competitors. This is 87% above median its historical median of 17.14. Over the past decade, ABH Healthcare's EBITDA Margin % has ranged from 6.12 to 28.49. According to the industry distribution chart, ABH Healthcare ranks #69 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is ABH Healthcare's EBITDA Margin % too high?
ABH Healthcare's current EBITDA Margin % of 31.98% is 87% above median its 10-year median of 17.14. Over the past 10 years, this metric has ranged from a low of 6.12 to a high of 28.49. The Healthcare Providers & Services industry median EBITDA Margin % is 10.18. ABH Healthcare's value of 31.98% is 214.1% above this industry median. Based on the distribution chart, ABH Healthcare ranks #69 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's EBITDA Margin % compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #69 out of 672 companies for EBITDA Margin %. This places ABH Healthcare in the top 10% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.18. ABH Healthcare's value of 31.98% is 214.1% above this benchmark. Historically, ABH Healthcare's own EBITDA Margin % has ranged from 6.12 to 28.49 over the past decade. While the company's 10-year median is 17.14 vs. the industry median of 10.18, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.18, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current EBITDA Margin % of 31.98% is 214.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current EBITDA Margin % is 31.98%, which is 87% above median its own 10-year median of 17.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current EBITDA Margin % of 31.98%. The current EBITDA Margin % is 31.98%, which is 87% above median its 10-year median of 17.14 and 214.1% above the Healthcare Providers & Services industry median of 10.18. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current EBITDA Margin % is 31.98% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
